1-509-375-1202 - 1-877-447-679
info@isoray.com
A leader in the development of isotope technologies for the treatment of cancer.
 
stock_info
SEC Filings
Webcasts
Press Releases
Analyst Reports
Request for Information
 
 
SEC Filings

Fiscal Year 2006

Fiscal Year 2007

Fiscal Year 2008

Form 4

 



 

Investor Relations

Michael Mason (investors)
Brian Kennedy (media)
Allen & Caron 212-691-8087
michaelm@allencaron.com
brian@allencaron.com

Jonathan Hunt
CFO, IsoRay Medical™

Phone: 509-375-1202
jhunt@isoray.com